Sign Out
Pregnancy: Category C. Adverse events were observed in animal reproduction studies. Information related to the use of EXSIROX in pregnant women is limited. The Canadian labeling recommends that Deferasirox not be used during pregnancy.
Lactation: It is not known if EXSIROX is excreted in breast milk. Due to the potential for serious adverse reactions in the breast-feeding infant, the manufacturer recommends a decision made to discontinue breastfeeding or the drug, taking into account the importance of treatment to the mother.
